AutologIX

AutologIX is a regenerative therapy system that concentrates autologous exosomes from platelet-rich plasma (PRP) derived from the patient's own blood. It is a ready-to-use, tested medical system comprising the ProtSmart6 ultracentrator and PRP1 tubes.

AutologIX enables clinics to move beyond conventional PRP by offering a simple, efficient, and clinic-friendly system to prepare an autologous exosome-rich fraction, derived entirely from the patient’s own blood.

Unlike the vast majority of plant exosome products on the market, which are supplied as topical-only solutions, AutologIX is designed to generate an autologous exosome-rich product intended
for injectable use by qualified medical professionals, in accordance with local regulations.

Key Benefits:
• ⁠Autologous & personalised – derived from the patient’s own blood.
• Single 8-minute centrifugation – fast and efficient preparation.
• ⁠No tube preparation required.
• ⁠Works with standard PRP centrifuges.
• Single-spin workflow.
• Advanced ultrafiltration technology.
• Easy integration into existing PRP protocols.

AutologIX is designed to fit seamlessly into modern aesthetic and regenerative clinics. The system is prepared using a single 8-minute centrifugation step, allowing for a rapid, practical workflow without unnecessary complexity.

Indications in Aesthetics:
• Skin rejuvenation with improvement in tone, texture, elasticity, and uniformity of the dermal layer
• Reduction of wrinkles and filling of fine lines
• Revitalization of the eye contour
• Revitalization of the skin on the hands, face, and neck
• Acceleration of skin healing after more invasive procedures, such as surgery
• Treatment of hair loss – alopecia areata and androgenic alopecia, support for hair transplants
• Reduction of inflammation and redness